Juluca Is the Latest Once-Daily Combo Med for HIV

February 2018

Juluca (jah-LOO-kah) will be a new two-drug combo for HIV.

It combines 50 mg of dolutegravir (Tivicay) and 25 mg of rilpivirine (Edurant) in a once-daily tablet.

Expect Juluca to be used for patients who've been on a stable regimen for at least six months...especially if they can't tolerate certain HIV meds or need fewer pills per day.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Salt Forms Know Your Way Around Salt Forms
Dispensing Optimize Use of Auxiliary Labels
Erectile Dysfunction Prevent Problems With Generic Viagra (Sildenafil)
Diabetes Meds Know How Bydureon BCise, Ozempic, and Steglatro Compare to Other Diabetes Meds
Monitoring Help Patients With FreeStyle Libre and Other Continuous Glucose Monitors
Medical Foods Clear Up Confusion About Medical Foods
HIV & AIDS Juluca Is the Latest Once-Daily Combo Med for HIV
Psoriasis Siliq and Tremfya Will Be the Latest "Biologics" for Psoriasis
Supplements Be Aware That Biotin May Skew Lab Test Results
Travel Medicine Keep the Different Meds Used for Altitude Sickness Straight
OTC Products Stay Alert for the Differences Among Dramamine Product
Practice Get Tools to Tackle This Flu Season
Women's Health Listen for Questions About Breast Cancer Risk With Hormonal Contraceptives

Juluca Is the Latest Once-Daily Combo Med for HIV

Practical advice for a better career, with unlimited access to CE

Table of Contents